1. Home
  2. CMPS vs POET Comparison

CMPS vs POET Comparison

Compare CMPS & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo COMPASS Pathways Plc American Depository Shares

CMPS

COMPASS Pathways Plc American Depository Shares

HOLD

Current Price

$6.93

Market Cap

611.6M

Sector

Health Care

ML Signal

HOLD

Logo POET Technologies Inc.

POET

POET Technologies Inc.

HOLD

Current Price

$7.17

Market Cap

550.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMPS
POET
Founded
2020
1972
Country
United Kingdom
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
611.6M
550.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
CMPS
POET
Price
$6.93
$7.17
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$16.43
N/A
AVG Volume (30 Days)
1.4M
8.2M
Earning Date
11-04-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$762,695.00
Revenue This Year
N/A
$2,939.08
Revenue Next Year
N/A
$710.17
P/E Ratio
N/A
N/A
Revenue Growth
N/A
535.87
52 Week Low
$2.25
$3.09
52 Week High
$7.13
$9.41

Technical Indicators

Market Signals
Indicator
CMPS
POET
Relative Strength Index (RSI) 64.62 60.44
Support Level $6.08 $5.81
Resistance Level $7.13 $7.90
Average True Range (ATR) 0.43 0.61
MACD 0.06 0.13
Stochastic Oscillator 86.84 64.35

Price Performance

Historical Comparison
CMPS
POET

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About POET POET Technologies Inc.

POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.

Share on Social Networks: